Shire buys Lumena for $260mm in cash
Just two months after closing a $45mm Series B financing, Lumena Pharmaceuticals Inc. (treatments for rare liver and metabolic diseases) was acquired by Shire PLC for $260mm in cash, plus a cash payment at closing and near-term earn-outs based on clinical development.
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com